nach oben

Journal of Hepato-Biliary-Pancreatic Sciences

Erschienen in:

01.03.2011 | Original article

Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis

verfasst von: Hitoshi Sano, Takahiro Nakazawa, Tomoaki Ando, Kazuki Hayashi, Itaru Naitoh, Fumihiro Okumura, Katsuyuki Miyabe, Michihiro Yoshida, Satoru Takahashi, Hirotaka Ohara, Takashi Joh

Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Only a few studies have documented the characteristics of inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC). We aimed to clarify the clinical and histopathological characteristics of IBD associated with PSC (PSC-IBD).

Methods

Twenty-nine patients with PSC and 60 patients with ulcerative colitis (UC) but without complicating PSC were enrolled in this study. First, the age and sex distribution, affected area, clinical course, number of recurrent attacks, and severity of UC were investigated. Then, mucosal specimens obtained from the right side (cecum and ascending colon), transverse colon, and the left side (descending colon, sigmoid colon, and rectum) during colonoscopy were studied for inflammatory cell infiltration, the presence of crypt abscesses, the degree of goblet cell disappearance, and edema.

Results

(1) The incidence of IBD in PSC patients was 68.9% (20/29). There were two peaks in the age distribution of PSC. Male PSC patients demonstrated a first peak and female patients a second peak. Male PSC-IBD patients were in their teens and 20s making the first peak. Female PSC-IBD patients were in their 50s and 60s making the second peak. The PSC-IBD patents were significantly younger than the patients without IBD (33.6 vs. 58.9 years, p < 0.001). (2) PSC-IBD showed a right-sided predominance colonoscopically. (3) None of the patients had a severe clinical course, and a half of them were asymptomatic. (4) Histopathological examination demonstrated severe inflammatory cell infiltration in the cecum and ascending colon, whereas the degree was mild in the rectum/descending colon.

Conclusions

PSC-IBD shows characteristic clinical, colonoscopic, and histopathological findings.

Vierling JM. In: Manns P, Chapman RW, Stiehl A, et al., editors. Primary sclerosing cholangitis. London: Kluwer; 1988. p. 37–45.

Lazaridis KN, Wiesner RH, Porayko MK, Ludwig J, LaRusso NF. Primary sclerosing cholangitis. In: Schiff ER, Sorrel MF, Maddrey WC, editors. Schiff’s disease of the liver. English Edition. Philadelphia: Lippincott-Raven; 1999. p. 649–78.

Lindor KD, LaRusso NF. Primary sclerosing cholangitis. In: Schiff L, Schiff ER, editors. Schiff’s disease of the liver, Nineth edition. Philadelphia: JB Lippincott; 2003. p. 673–84.

Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;430–36.

Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan—analysis of 192 cases. J Gastroenterol. 1997;32:134–7.PubMedCrossRef

Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan. Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153–9.PubMedCrossRef

Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al. PSC–IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–6.PubMedCrossRef

Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, et al. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol. 2008;14:3497–503.PubMedCrossRef

Uchida N, Ezaki T, Fukuma H, Tsutsui K, Kobara H, Matsuoka M, et al. Concomitant colitis associated with primary sclerosing cholangitis. J Gastroenterol. 2003;38:482–7.PubMedCrossRef

10.

Oshitani N, Jinno Y, Sawa Y, Nakamura S, Matsumoto T, Nishiguchi S, et al. Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis? Hepatogastroenterology. 2003;50:1830–5.PubMed

11.

Yamagishi N, Iizuka B. Ulcerative colitis and primary sclerosing cholangitis: colonoscopic features of concomitant colitis with primary sclerosing cholangitis (in Japanese). Kan Tan Sui. 2004;49:221–8.

12.

Tanaka M, Riddell RH. The pathological diagnosis and differential diagnosis of Crohn’s disease. Hepatogastroenterology. 1990;27:18–31.

13.

Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease-“colitis indeterminate”. J Clin Pathol. 1978;31:567–77.PubMedCrossRef

14.

Lee KS, Medline A, Shockey S. Indeterminate colitis in the spectrum of inflammatory bowel disease. Arch Pathol Lab Med. 1979;103:173–6.PubMed

15.

Matsui T, Yao T, Sakurai T, Yao K, Hirai F, Matake H, et al. Clinical features and pattern of indeterminate colitis: Crohn’s disease with ulcerative colitis-like clinical presentation. J Gastroenterol. 2003;38:647–55.PubMedCrossRef

16.

Hiwatashi N. Criteria for diagnosis of ulcerative colitis (preliminary proposal). In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan; 1993. p. 90–2.

17.

Gilaad GK, Kevin BL, Decker B, Stefan JU, Samuel SL. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102:1042–9.CrossRef

18.

Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20–5.PubMed

19.

Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholantis. Gastrointest Endosc. 2004;60:937–44.PubMedCrossRef

20.

Utsunomiya T, Katsumata T, Nakayama T, Kitahora T, Ohara S, Yokota H, et al. Prevalence of ulcerative colitis (1973–1991). In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan; 1993. p. 274–8.

21.

Bentley DW, Nicholos RL, Condon RE, Gorbach SL. The microflora of the human ileum and intra-abdominal colon: results of direct needle aspiration at surgery and evaluation of the technique. J Lab Clin Med. 1972;79:421–9.PubMed

22.

Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal PH profiles in normal ambulant human subjects. Gut. 1988;29:1035–41.PubMedCrossRef

23.

Nair PP, Gordon M, Reback J. The enzymatic cleavage of the carbon-nitrogen bond in 3a, 7a, 12a-trihydroxy-5b-cholan-24-oyl glycine. J Biol Chem. 1967;243:7–11.

24.

Stellwag EJ, Hylemon PB. 7a Dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J Lipid Res. 1979;20:325–33.PubMed

25.

Thomas LA, Veysey MJ, French G, Hylemon PB, Murphy GM, Dowling RH. Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples. Gut. 2001;49:835–42.PubMedCrossRef

26.

Palmer RH. Bile acids, liver injury, and liver disease. Arch Intern Med. 1972;130:606–17.PubMedCrossRef

27.

Yamada S, Ishii M, Liang LS, Yamamoto T, Toyota T. Small duct cholangitis induced by N-formyl l-methionine l-leucine l-tyrosine in rats. J Gastroenterol. 1994;29:631–6.PubMedCrossRef

28.

Morita N, Furuno S, Siraki K, Sawada T, Muto T, Tamakosi A, et al. Nationwide epidemiological survey of IBD. In: Muto T, editor. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan; 1994. p. 176–83.

29.

Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:1643–9.PubMedCrossRef

30.

Brentnall TA. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996;110:331–8.PubMedCrossRef

31.

Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, LaRusso NF, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213:21–5.PubMedCrossRef

Titel: Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis
verfasst von: Hitoshi Sano
Takahiro Nakazawa
Tomoaki Ando
Kazuki Hayashi
Itaru Naitoh
Fumihiro Okumura
Katsuyuki Miyabe
Michihiro Yoshida
Satoru Takahashi
Hirotaka Ohara
Takashi Joh
Publikationsdatum: 01.03.2011
Verlag: Springer Japan
Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences / Ausgabe 2/2011
Print ISSN: 1868-6974
Elektronische ISSN: 1868-6982
DOI: https://doi.org/10.1007/s00534-010-0319-8

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Novel postoperative adjuvant strategy prevents early hepatic recurrence after resection of pancreatic cancer

Clinical impact of endoscopic papillectomy for benign–malignant borderline lesions of the major duodenal papilla

Prognosis and treatment of pancreaticoduodenal traumatic injuries: which factors are predictors of outcome?

Clinical significance of bile cytology via an endoscopic nasobiliary drainage tube for pathological diagnosis of malignant biliary strictures

Large cystic acinar cell carcinoma of the pancreas

Endoscopic ultrasonography-guided gallbladder drainage: actual technical presentations and review of the literature (with videos)

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“